Growing Through Challenges? – Viracta Therapeutics Inc (VIRX)
Currently, there are 39.74M common shares owned by the public and among those 27.91M shares have been available to trade. The company’s stock has a 5-day price change of 5.03% and -30.19% over the past three months. VIRX shares are trading -71.44% year to date (YTD), with the 12-month market performance down to -66.71% lower. […]
Viracta Therapeutics Inc (VIRX): Not A Time To Panic Nor Freeze
Viracta Therapeutics Inc (VIRX) concluded trading on Wednesday at a closing price of $0.19, with 10.97 million shares of worth about $2.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.80% during that period and on November 06, 2024 the price saw a […]
Viracta Therapeutics Inc (NASDAQ: VIRX): The Best-Of-Breed For Investing?
Currently, there are 39.09M common shares owned by the public and among those 27.71M shares have been available to trade. The company’s stock has a 5-day price change of -3.12% and -51.56% over the past three months. VIRX shares are trading -59.21% year to date (YTD), with the 12-month market performance down to -63.67% lower. […]
